Literature DB >> 8792758

The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome.

H A Sackeim1, B Luber, G P Katzman, J R Moeller, J Prudic, D P Devanand, M S Nobler.   

Abstract

BACKGROUND: The efficacy of electroconvulsive therapy (ECT) is determined by stimulus electrical intensity and electrode placement. Three theories offer different accounts for why increasing the stimulus dosage of right unilateral ECT enhances antidepressant effects. This study examined the effects of ECT on interictal quantitative electroencephalograms (EEGs), contrasting these theories in their predictions regarding global, lateralized, and topographic changes in ECT-induced slow-wave activity. The time course of EEG changes and associations with efficacy were also determined.
METHODS: Sixty-two inpatients with major depressive disorder were randomized to ECT conditions that differed in stimulus intensity (low vs high dosage) and electrode placement (right unilateral vs bilateral). Resting, eyes closed, 19-lead EEG recordings were obtained at pretreatment, following a single treatment, following an average of 7 treatments, during the week following the ECT course, and after a 2-month follow-up period.
RESULTS: Electroconvulsive therapy produced a marked short-term increase in delta and theta power. At a 2-month follow-up, there were no significant alterations in any frequency band. The ECT treatment conditions differed markedly in efficacy. Global and lateralized EEG effects did not distinguish effective and ineffective forms of treatment. Effective forms of ECT resulted in increased delta power in prefrontal regions, and this change was associated with the magnitude of symptomatic improvement.
CONCLUSION: The induction of slow-wave activity in prefrontal cortex is linked to the efficacy of ECT.

Entities:  

Mesh:

Year:  1996        PMID: 8792758     DOI: 10.1001/archpsyc.1996.01830090060009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  30 in total

1.  Central-Positive Complexes: A Novel Characterization of Ictal Markers Induced During Electroconvulsive Therapy.

Authors:  R Edward Hogan; Emma R Trammel; Nuri B Farber; Michael S Avidan; Ben Julian A Palanca
Journal:  J ECT       Date:  2019-12       Impact factor: 3.635

2.  Decreased creatine kinase activity caused by electroconvulsive shock.

Authors:  Márcio Búrigo; Clarissa A Roza; Cintia Bassani; Gustavo Feier; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

Review 3.  Meta-analysis of initial seizure thresholds in electroconvulsive therapy.

Authors:  Jeroen A van Waarde; Bastiaan Verwey; Rose C van der Mast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-21       Impact factor: 5.270

4.  An Electrophysiological Biomarker That May Predict Treatment Response to ECT.

Authors:  Katherine W Scangos; Richard D Weiner; Edward C Coffey; Andrew D Krystal
Journal:  J ECT       Date:  2019-06       Impact factor: 3.635

5.  Principal components of electrocortical activity during self-evaluation indicate depressive symptom severity.

Authors:  Allison C Waters; Don M Tucker
Journal:  Soc Cogn Affect Neurosci       Date:  2016-04-06       Impact factor: 3.436

Review 6.  The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders.

Authors:  Dietrich van Calker; Knut Biber
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

7.  Bispectral EEG (BSEEG) to assess arousal after electro-convulsive therapy (ECT).

Authors:  Kasra Zarei; Nicholas A Sparr; Nicholas T Trapp; Elena D Neuhaus; John W Cromwell; Aaron D Boes; Gen Shinozaki
Journal:  Psychiatry Res       Date:  2020-01-25       Impact factor: 3.222

8.  A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development.

Authors:  Laura Kranaster; Suna Su Aksay; Jan Malte Bumb; Carolin Hoyer; Christine Jennen-Steinmetz; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-06       Impact factor: 5.270

9.  A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT).

Authors:  Gregory L Sahlem; William V McCall; E Baron Short; Peter B Rosenquist; James B Fox; Nagy A Youssef; Andrew J Manett; Suzanne E Kerns; Morgan M Dancy; Laryssa McCloud; Mark S George; Harold A Sackeim
Journal:  Brain Stimul       Date:  2020-07-29       Impact factor: 8.955

10.  Rapid antidepressant effects: moving right along.

Authors:  K Martinowich; D V Jimenez; C A Zarate; H K Manji
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.